Detailed answers about DRUG DEVELOPMENT SOLUTIONS LIMITED, including incorporation, status, business activity, and accounts information.
When was DRUG DEVELOPMENT SOLUTIONS LIMITED founded?
DRUG DEVELOPMENT SOLUTIONS LIMITED was officially incorporated on 17 March 2022 and is registered under company number 13985205. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is DRUG DEVELOPMENT SOLUTIONS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of DRUG DEVELOPMENT SOLUTIONS LIMITED?
DRUG DEVELOPMENT SOLUTIONS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does DRUG DEVELOPMENT SOLUTIONS LIMITED do?
DRUG DEVELOPMENT SOLUTIONS LIMITED operates in the following sector: 74909 - Other professional, scientific and technical activities n.e.c.. This provides insight into the company's primary business activity and industry focus.
What is DRUG DEVELOPMENT SOLUTIONS LIMITED's registered address?
The registered office address of DRUG DEVELOPMENT SOLUTIONS LIMITED is RESOLIAN NEWMARKET ROAD, FORDHAM, ELY, ENGLAND, CB7 5WW. This is the official address filed with Companies House for legal and statutory correspondence.
Is DRUG DEVELOPMENT SOLUTIONS LIMITED financially stable?
The most recent accounts for DRUG DEVELOPMENT SOLUTIONS LIMITED were made up to 31 December 2024, filed as FULL. Next accounts are due by 30 September 2026.
Does DRUG DEVELOPMENT SOLUTIONS LIMITED have any charges or mortgages?
DRUG DEVELOPMENT SOLUTIONS LIMITED has 2 registered charges, of which 2 are outstanding, 0 satisfied, and 0 part satisfied. Charges are typically registered when a company uses its assets as security for borrowing.
Has DRUG DEVELOPMENT SOLUTIONS LIMITED changed its name?
Yes, DRUG DEVELOPMENT SOLUTIONS LIMITED has had 1 previous name: LGC RHODES LIMITED (changed 19 May 2022).